FDAClass IIIFebruary 1, 2017

Azelastine Hydrochloride Nasal Solution recall

Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99

Why was Azelastine Hydrochloride Nasal Solution recalled?

Defective Delivery System: out of specification result for droplet size distribution at the d90 measurement testing during the 6 month time point..

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot # 659365A, Exp 3/31/2018

Product
Azelastine Hydrochloride Nasal Solution (Nasal Spray), 0.1% (137 mcg per spray), packaged in 30 mL bottles, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724, NDC 0054-0293-99
Recalling firm
Roxane Laboratories, Inc.
Quantity
74,108 bottles
Distribution
Nationwide and Puerto Rico.
Recall date
February 1, 2017
Classification
Class III
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls